For an Executive Summary of this report or if you wish to see full Sample Pages please contact Ediz Ibrahim at ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976)
2. Contents
1. Executive Summary
1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Telemedicine
2. An Introduction to Telemedicine and Telehealth
2.1 Telemedicine, Telehealth, and Telecare: A Concise Definition
2.1.1 Telecare: An All-Encompassing Field
2.1.2 Telehealth: For Monitoring and Health Maintenance
2.1.3 Telemedicine: Consultation, Diagnosis, Treatment
2.2 Rising Disease Prevalence: A Global Picture
2.3 Telemedicine: A Journey through History
2.4 mHealth: Mobile Communications to Transform Healthcare
2.5 Commonly Used Measuring Devices in Telemedicine
2.5.1 Blood Glucose Monitors
2.5.2 Blood-Pressure Monitors
2.5.3 Weight Scales
2.5.4 Pulse Oximeters
2.5.5 Peak Flow Meters
2.6 Medical Devices Classification Systems
2.6.1 The US Medical Devices Classification System
2.6.2 The EU Medical Devices Classification System
2.7 Regulation of Medical Devices
2.7.1 The US Approval and Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Post-marketing Surveillance in the EU
www.visiongain.com
3. Contents
3. The Global Telemedicine Market: by Therapeutic Indication 2014-2024
3.1 The Global Medical Device Market in 2013
3.2 Telemedicine: Global Market Overview
3.2.1 The Global Telemedicine Devices Market in 2013
3.2.2 Global Telemedicine Devices: Market Forecast 2014-2024
3.2.3 Changing Market Shares by Sector 2014-2024
3.3 Telemedicine Devices for Cardiac Diseases Market 2014-2024
3.3.1 Cardiac Diseases: A Major Cause of Death in Developed Economies
3.3.2 Telemedicine Devices for Cardiac Diseases: Market Forecast 2014-2024
3.4 Telemedicine Devices for COPD and Asthma Market 2014-2024
3.4.1 COPD and Asthma: Rising Prevalence
3.4.2 Telemedicine Devices for COPD and Asthma: Market Forecast 2014-2024
3.5 Telemedicine Devices for Diabetes Market 2014-2024
3.5.1 Diabetes: Rapid Technological Advances in Monitoring and Treatment
3.5.2 Telemedicine Devices for Diabetes: Market Forecast 2014-2024
3.6 Telemedicine Devices for Mental-health Related Illnesses Market 2014-2024
3.6.1 Telemedicine Devices for Use in Mental-health Related Illnesses
3.6.2 The Issue of Capacity, Consent, and Privacy in the Treatment of Mental Disorders
3.6.3 Cognitive Behaviour Therapy and the Use of Apps in the Management of Mental
Disorders
3.6.4 The Phyode W/ME and the Life Spectrum Analyzer
3.6.5 Telemedicine Devices for Mental-health Related Illnesses: Market Forecast 20142024
3.7 Telemedicine Devices Used in the Treatment of Other Illnesses
3.7.1 Obstructive Sleep Apnea and Post Traumatic Stress Disorder
3.7.2 Telemedicine Devices Used in the Treatment of Other Illnesses: Market Forecast
2014-2024
www.visiongain.com
4. Contents
4. Leading National Markets 2014-2024
4.1 The Telemedicine Devices Market by Regional Revenue
4.1.1 The Global Distribution of Telemedicine in 2013
4.2 Leading National Markets: Forecast, 2014-2024
4.2.1 Changing Market Shares by Region, 2014-2024
4.3 Regional Telemedicine Devices Markets: Analysis and Forecasts, 2014-2024
4.3.1 United States: The Largest Telemedicine Market
4.3.2 The EU5 Markets: Increasing Focus on Access to Quality Healthcare
4.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
4.3.2.2 Germany: Biggest European Telemedicine Market
4.3.2.3 The UK: Government Initiatives Driving Telemedicine Uptake
4.3.2.4 France: A Tale of Reimbursement Struggles and Cost Cutting
4.3.2.5 Spain: Austerity Drive Weighing On Medical Technology
4.3.2.6 Italy: Ageing Population and Reforms in Healthcare Financing
4.3.3 Japan: Language Barrier and Complex Regulatory Guidelines Hindering Growth
4.3.4 China: A Great Leap Forward in Teleconferencing
4.3.5 South Korea: Rebranding Efforts Will Contribute to Market Growth
4.3.6 Russia: Pressing Need for Healthcare Extension to Remote Territories
4.3.7 India: A Rapidly Growing Medical Technology Market
4.3.8 Brazil: Social Inequalities and Uneven Healthcare Distribution
5. Telemedicine, Telehealth, and mHealth: Analysis and Trends
5.1 Telemedicine as a Package of Connected Devices
5.1.1 Telemedicine: Applications and Uses
5.1.2 Telemedicine: Issues Surrounding its Implementation
5.2 Factors Which Could Facilitate Telemedicine Development
5.2.1 The Establishment of National Agencies
5.2.2 Collaboration between Scientific Bodies
www.visiongain.com
5. Contents
5.2.3 Legislative Interventions: The Affordable Care Act
5.3 mHealth
5.3.1 Mobile Devices Have the Potential to Become Powerful Medical Tools
5.3.2 The Rise of Mobile Medical Applications
5.3.3 Functions of mHealth
5.3.4 mHealth and GPS Tracking: A Possible Marriage with Benefits
5.3.5 The mHealth Initiative: An ITU and WHO Partnership
5.3.6 Overcoming the Obstacles to mHealth Uptake
5.3.7 Recommended Actions for Increasing mHealth Uptake
5.3.7.1 Maintain Low Costs
5.3.7.2 Gain the Approval of the Healthcare Practitioners
5.3.7.3 Solutions Should Offer Ease of Use and Increased Efficiency
5.3.8 V-Patch and Zensor: Remote monitoring From Intelesens
5.4 Pipeline Projects
5.4.1 CareLink System - Medtronic
5.4.2 CX65 mobile phone - Siemens
5.4.3 Telemonitoring System for Dementia Patients - Intel
5.4.4 MDKeeper Wearable eHealth System – Aerotel Medical Systems
6. Leading Companies in the Telemedicine Market 2014
6.1 3M: A Global Health Information Systems Provider
6.1.1 3M Healthcare Revenue Analysis, 2013
6.1.2 3M’s Telemedicine Products and Services
6.2 Aerotel Medical Systems
6.2.1 Aerotel’s Products and Services
6.3 AGFA Healthcare
6.3.1 AGFA: Radiology and Imaging Solutions
6.4 AMD Global Telemedicine Inc
6.4.1 AMD Global Telemedicine’s Products and Services
6.5 CardioComm
www.visiongain.com
6. Contents
6.5.1 CardioComm Pipeline Products
6.6 Honeywell HomMed
6.6.1 Honeywell HomMed Telemedicine Products and Services
6.7 Medtronic
6.7.1 Medtronic: Revenue Analysis
6.7.2 Medtronic’s Telemedicine System
6.8 Philips Healthcare
6.8.1 Philips Healthcare: Revenue Analysis
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare: Revenue Analysis
6.10 Telcare
6.10.1 Telcare’s Market and Business Model
6.10.2 Telcare’s Products and Services
7. Qualitative Analysis
7.1 SWOT Analysis of the Telemedicine Devices Market, 2014-2024
7.2 Strengths
7.2.1 The Increasing Prevalence of Diseases
7.2.2 The Rising Popularity of Home Monitoring
7.2.3 The Willingness of Telecommunication Companies to Invest
7.3 Weaknesses
7.3.1 The Threat of Replacement Perceived by Healthcare Professionals
7.3.2 The Inter-dependence of Telemedicine and Other Infrastructure
7.4 Opportunities
7.4.1 Potential for Use in Clinical Trials
7.4.2 Possibility of Integrating with Assisted Living
7.4.3 Benefits to Society beyond Healthcare
7.5 Threats
7.5.1 The High Cost of Implementing Telemedicine
7.5.2 High Barrier to Entry: A Strong Deterrent
www.visiongain.com
7. Contents
7.5.3 Reluctance of Organisations to Share and Exchange Knowledge
8. Expert Opinion
8.1 Interview with Ms Stacey Force, Vice President of Marketing, Honeywell HomMed
8.1.1 The Scope of Telemedicine, Telehealth and Telemonitoring
8.1.2 On the Current State of the Telemedicine and Telehealth Market
8.1.3 On the Size of the Telemonitoring Market
8.1.4 Honeywell’s Products and Service Offerings
8.1.5 Honeywell’s Plans for Expansion and Growth
8.1.6 The Challenges Facing Telemedicine
8.1.7 Technological Developments and their Potential Impact on the Market
8.1.8 The Changing Reimbursement Model and Cost-Effectiveness
8.2 Interview with Mr. Jason Gorevic, Chief Executive Officer, Teladoc
8.2.1 Trends in the Development and Adoption of Telemedicine
8.2.2 Teleadoc’s Services and Healthcare Partnerships
8.2.3 Plans for Future Expansion of Telemedicine Services and Mobile Engagement
8.2.4 On the Challenges and Unmet Needs in the Market
8.2.5 Technological Developments in Remote Healthcare Provision
8.2.6 On the Future Prospects of Telemedicine
8.3 Interview with Mr David Rubin, Chief Executive Officer, Aerotel Medical Systems
8.3.1 Current State of Telemedicine
8.3.2 Aerotel’s Products and Service Offerings
8.3.3 Challenges Facing Telemedicine and Telehealth
8.3.4 Opportunities for Market Growth
8.4 Interview with Mr Amnon Gavish, Senior Vice President of Vertical Solutions, Vidyo; and Mr
Marty Hollander, Vidyo Evangelist, Vidyo
8.4.1 Telepresence as a Means of Improving Healthcare Efficiency
8.4.2 Vidyo’s Teleconferencing Solutions
8.4.3 Technological Advances in Telemedicine and its Effects on Market Dynamics
8.4.4 Vidyo’s Expansion and Growth Plans
www.visiongain.com
8. Contents
8.4.5 The Geographical Areas That Will Drive Telehealth Growth
8.4.6 On the Future Potentials of Telemedicine and Teleconferencing
8.4.7 On the Challenges and Opportunities in the Telemedicine Market
9. Conclusion
9.1 Market Overview
9.2 Telemedicine Devices for Diabetes Care Set for Rapid Growth
9.3 Technologically Developed Economies will Drive Market Growth
www.visiongain.com
9. Contents
List of Tables
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 The Medical Devices Market: Revenues ($bn) and Market Shares (%) by Sector, 2012
Table 3.2 The Global Telemedicine Devices Market: Revenue ($m) and Market Shares (%) by
Sector, 2013
Table 3.3 The Global Telemedicine Devices Market: Market Forecast ($m, AGR%, CAGR%) by
Sector, 2013-2024
Table 3.4 Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2018, 20182024, 2013-2024
Table 3.5 The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
Table 3.6 The Global Telemedicine Devices Market: Market Share (%) by Sector, 2013, 2018,
2024
Table 3.7 The Telemedicine Devices Market for Cardiac Diseases: Market Forecast ($m, AGR%,
CAGR%), 2013-2024
Table 3.8 The Telemedicine Devices Market for COPD and Asthma: Market Forecast ($m, AGR%,
CAGR%), 2013-2024
Table 3.9 The Telemedicine Devices Market for Diabetes: Market Forecast ($m, AGR%,
CAGR%),
2013-2024
Table 3.10 The Telemedicine Devices Market for Mental-health Related Illnesses: Market
Forecast ($m, AGR%, CAGR%), 2013-2024
Table 3.11 The Telemedicine Devices Market for Other Illnesses: Market Forecast ($m, AGR%,
CAGR%), 2013-2024
Table 4.1 The Global Telemedicine Devices Market: Revenue ($m) and Market Share (%) by
Region, 2013
Table 4.2 The Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%) by Region,
2013-2024
Table 4.3 Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2018, 2018-2024,
www.visiongain.com
10. Contents
and 2013-2024
Table 4.4 Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2013, 2018,
2024
Table 4.5 US Telemedicine Devices Market Forecast: Revenue ($m), Rank, Market Share (%) and
CAGR (%), 2013-2024
Table 4.6 US Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
Table 4.7 The EU5 Telemedicine Devices Market Forecast: Market Size ($m), Market Share (%)
and CAGR (%), 2013-2024
Table 4.8 The EU5 Telemedicine Devices Market: Revenue ($m) and Market Share (%) by
Country, 2013
Table 4.9 The EU5 Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%) by
Country, 2013-2024
Table 4.10 EU5 Telemedicine Devices Market: Market Share (%) by Country, 2013, 2018, 2024
Table 4.11 The German Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.12 The German Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 20132024
Table 4.13 The UK Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market
Share (%) and CAGR (%), 2013-2024
Table 4.14 The UK Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
Table 4.15 The French Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.16 The French Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
Table 4.17 The Spanish Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.18 The Spanish Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 20132024
Table 4.19 The Italian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.20 The Italian Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
Table 4.21 The Japanese Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
www.visiongain.com
11. Contents
Market Share (%) and CAGR (%), 2013-2024
Table 4.22 The Japanese Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%),
2013-2024
Table 4.23 The Chinese Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.24 The Chinese Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%),
2013-2024
Table 4.25 The South Korean Telemedicine Devices Market Forecast: Revenue ($m), Market
Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.26 The South Korean Telemedicine Devices Market: Revenue Forecast ($m, AGR%,
CAGR%), 2013-2024
Table 4.27 The Russian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.28 The Russian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%),
2013-2024
Table 4.29 The Indian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.30 The Indian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%),
2013-2024
Table 4.31 The Brazilian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank,
Market Share (%) and CAGR (%), 2013-2024
Table 4.32 The Brazilian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%),
2013-2024
Table 5.1 Devices, Mobile Technologies and Their Use in mHealth
Table 5.2 Mobile Health Apps and Their Features, 2014
Table 5.3 An Overview of Functions in mHealth
Table 5.4 Components of Intelesens’ V-Patch System, 2014
Table 6.1 3M: Revenue ($m) and Revenue Shares (%) by Franchise, 2012
Table 6.2 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2012
Table 6.3 Aerotel Medical Systems’ Products and Services, 2014
Table 6.4 AGFA Healthcare’s Telemedicine Products and Services, 2014
www.visiongain.com
12. Contents
Table 6.5 AMD Global Telemedicine’s Products and Services, 2014
Table 6.6 CardioComm Pipeline Products and Descriptions, 2014
Table 6.7 Honeywell: Revenue ($bn) and Revenue Shares (%) by Sector, 2012
Table 6.8 Honeywell HomMed Products and Descriptions, 2014
Table 6.9 Medtronic: Revenues ($bn) and Revenue Shares (%) by Franchise, 2013
Table 6.10 Medtronic: Revenues ($bn) and Revenue Shares (%) by Region, 2013
Table 6.11 Philips Healthcare Medical Devices: Revenues ($bn) and Revenue Shares (%) by
Sector, 2012
Table 6.12 Philips Healthcare: Revenues ($bn) and Revenue Shares (%) by Region, 2012
Table 6.13 Siemens Healthcare Medical Devices: Revenues ($bn) and Revenue Shares (%) by
Region, 2012
Table 6.14 Telcare: Products and Descriptions, 2014
Table 7.1 Telemedicine Devices: Market Drivers and Restraints 2014-2024
Table 7.2 SWOT Analysis of the Telemedicine Devices Market, 2014-2024
Table 9.1 Global Telemedicine Devices: Market Forecast ($m, CAGR%), 2013, 2018, 2021, 2024
Table 9.2 Global Telemedicine Devices: Market Forecast ($m, CAGR%) by Sector, 2013, 2018,
2021, 2024
Table 9.3 Global Telemedicine Devices: Market Share (%) by Region, 2013, 2018, 2021, 2024
www.visiongain.com
13. Contents
List of Figures
Figure 2.1 The Similarities and Differences Between Telecare and Telehealth
Figure 2.2 The Similarities and Differences Between Telehealth and Telemedicine
Figure 2.3 Global Deaths from Cardiovascular Diseases (millions), 2008, 2030
Figure 2.4 The Parties Involved in the Provision of mHealth
Figure 3.1 The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013
Figure 3.2 The Global Telemedicine Devices Market: Market Forecast ($m, AGR%), 2013-2024
Figure 3.3 Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2018
Figure 3.4 Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2018-2024
Figure 3.5 Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2024
Figure 3.6 The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
Figure 3.7 The Global Telemedicine Devices Market: Market Share (%) by Sector, 2013
Figure 3.8 The Global Telemedicine Devices Market: Market Share (%) by Sector, 2018
Figure 3.9 The Global Telemedicine Devices Market: Market Share (%) by Sector, 2024
Figure 3.10 The Telemedicine Devices Market for Cardiac Diseases: Market Forecast ($m,
AGR%), 2013-2024
Figure 3.11 The Telemedicine Devices Market for COPD and Asthma: Market Forecast ($m,
AGR%), 2013-2024
Figure 3.12 The Telemedicine Devices Market for Diabetes: Market Forecast ($m, AGR%), 20132024
Figure 3.13 The Telemedicine Devices Market for Mental-health Related Illnesses: Market
Forecast ($m, AGR%), 2013-2024
Figure 3.14 The Telemedicine Devices Market for Other Illnesses: Market Forecast ($m, AGR%),
2013-2024
Figure 4.1 The Global Telemedicine Devices Market: Revenue ($m) by Region, 2013
Figure 4.2 US, EU5, Japan, and South Korea Telemedicine Devices Market: Revenue Forecast
($m), 2013-2024
Figure 4.3 Brazil, Russia, India, and China (BRIC) Telemedicine Devices Market: Revenue
Forecast ($m), 2013-2024
Figure 4.4 Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2018
www.visiongain.com
14. Contents
Figure 4.5 Telemedicine Devices Market Forecast: CAGR (%) by Region, 2018-2024
Figure 4.6 Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2024
Figure 4.7 Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2013
Figure 4.8 Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2018
Figure 4.9 Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2024
Figure 4.10 US Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
Figure 4.11 The EU5 Telemedicine Devices Market: Market Size ($m) by Country, 2013
Figure 4.12 Germany, UK, France, Spain, and Italy Telemedicine Devices Market: Revenue
Forecast ($m), 2013-2024
Figure 4.13 The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2013
Figure 4.14 The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2018
Figure 4.15 The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2024
Figure 4.16 The German Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.17 The UK Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
Figure 4.18 The French Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.19 The Spanish Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.20 The Italian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
Figure 4.21 The Japanese Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.22 The Chinese Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.23 The South Korean Telemedicine Devices Market: Revenue Forecast ($m, AGR%),
2013-2024
Figure 4.24 The Russian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
Figure 4.25 The Indian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
Figure 4.26 The Brazilian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 20132024
www.visiongain.com
15. Contents
Figure 5.1 Functions Where Telemedicine Solutions are Utilized
Figure 5.2 Global Deaths from Communicable and Non-Communicable Diseases (%)
Figure 6.1 3M: Revenue Shares (%) by Franchise, 2012
Figure 6.2 3M: Historical Healthcare Revenue ($bn), 2008-2012
Figure 6.3 Honeywell: Revenue Shares (%) by Sector, 2012
Figure 6.4 Medtronic: Revenue Shares (%) by Franchise, 2013
Figure 6.5 Medtronic: Revenue Shares (%) by Region, 2013
Figure 6.6 Philips Healthcare Medical Devices: Revenue Shares (%) by Sector, 2012
Figure 6.7 Philips Healthcare: Revenues ($bn) by Region, 2012
Figure 6.8 Siemens Healthcare Medical Devices: Revenue Shares (%) by Region, 2012
Figure 9.1 Global Telemedicine Devices: Market Forecast ($m, CAGR%), 2013, 2018, 2021,
2024
Figure 9.2 Global Over-60 Population Forecast (%): 1950, 2009, 2050
Figure 9.3 Global Telemedicine Devices: Market Forecast ($m, CAGR%) by Sector, 2013, 2018,
2021, 2024
Figure 9.4 Global Telemedicine Devices: Market Share (%) by Region, 2013, 2018, 2021, 2024
www.visiongain.com
16. Contents
Companies Mentioned in this Report
3M
Accenture
Aerotel Medical Systems
AGFA Healthcare
Allied Telesis
Almeda GMBH
AMD Global Telemedicine
Apple
AT&T
Bayer AG
Bosch Healthcare
CardioComm
Confidant Inc
Fast Company
Fitbit
Google
Honeywell
IBM
Ideal Life
INOVELAN
Intelesens Ltd
Medtronic
Microsoft
Mitra Imaging Inc [AGFA]
Nike
Philips Healthcare
Phyode
Polycom
www.visiongain.com
18. Contents
Organisations Mentioned in this Report
American Telemedicine Association
Cellular Telephone Institute of America
Center for Disease Control [US]
Columbia University
Department of Health [UK]
Food and Drug Administration [US]
Health Resources Services Administration [US]
International Diabetes Federation
International Medical Device Regulators Forum
International Telecommunication Union
Ministry of Health [Kazakhstan]
National Committee for Quality Assurance [US]
National Health Service [UK]
South Carolina Heart Center
The American Heart Association
The Centres for Medicare and Medicaid Services [US]
The Japanese Red Cross Kitami Hospital
US Medicare and Medicaid Services, Health Care Financing Administration
Veteran’s Health Administration [US]
Wireless Life Sciences Alliance
World Health Organisation
www.visiongain.com
19. Telemedicine Devices Market Forecast 2014-2024:
Telehealth, mHealth & Future Prospects for Leading
Companies
Table 4.16 The French Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%),
2013-2024
2013
French Market
($m)
AGR (%)
CAGR (%) 2013-18
CAGR (%) 2013-24
2014
2015
2016
2017
2018
2019
41.3
47.7
54.8
63.9
76.3
90.0
107.1 126.9 150.4 176.7 205.0 237.8
15
15
16.8
17
19
18
19
2018-24
17.2
2020
19
2021
19
2022
2023
18
17.6
2024
16
16
Source: Visiongain 2014
Figure 4.18 The French Telemedicine Devices Market: Revenue Forecast ($m, AGR%),
2013-2024
Revenue ($m)
AGR (%)
20
150
15
100
10
50
5
AGR (%)
25
200
Revenue ($m)
250
0
0
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Year
Source: Visiongain 2014
4.3.2.5 Spain: Austerity Drive Weighing On Medical Technology
The Spanish telemedicine devices market was valued at $31.6m in 2013, accounting for 12.3% of
the EU5 market (Table 4.17).
www.visiongain.com
Page 82